مجله اخلاق زیستی- علمی پژوهشی

1. Mullard A. Mediator scandal rocks French medical community. The Lancet. 2011; 377(9769): 890-892.

2. De Figueiredo A, Simas C, Karafillakis E, Paterson P, Larson HJ. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. The Lancet. 2020; 396(10255): 898-908.

3. Guimier L. Vaccine resistance in France: Continuity and ruptures in light of the COVID-19 pandemic. Herodote. 2021; 183(4): 227-250.

4. SYNTHÈSE des données de surveillance de la rougeole du 1er janvier 2008 au 30 septembre 2019. Point de situation au 08 octobre 2019. Santé Publique France, 28 octobre 2019. Disponível em: https:// www.santepubliquefrance.fr/Maladies-ettraumatismes/Maladies-a-prevention-vaccine/ sarampo/documentos/boletim-nacional/resumo-dos-dados-de-vigilância-do-sarampode-1-janeiro-2008-a-30-setembro-2019. Acesso em: 15 fev. 2024.

5. Robinson E, Jones A, Daly M. International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples. Vaccine. 2021; 39(15): 2024-2034.

6. Verger P, Fressard L, Collange F, Gautier A, Jestin C, Launay O, Raude J, Pulcini C, Peretti-Watel P. Vaccine hesitancy among general practitioners and its determinants during controversies: a national cross-sectional survey in France. EBioMedicine. 2015 ; 2(8): 891-897.

7. Larson HJ, De Figueiredo A, Xiahong Z, Schulz WS, Verger P, Johnston IG, Cook AR, Jones NS. The state of vaccine confidence 2016: global insights through a 67-country survey. EBioMedicine. 2016 ; 12: 295-301.

8. Sudlow B. The Frenchness of Marcel Lefebvre and the Society of St Pius X: a new reading. French Cultural Studies. 2017; 28(1): 79-94.

9. Ward JK, Alleaume C, Peretti-Watel P, Seror V, Cortaredona S, Launay O, Raude J, Verger P, Beck F, Legleye S, L'Haridon O. The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue. Social science & medicine. 2020; 265:113414.

10. Lequillerier C. La vaccination au prisme du droit pénal. RDSS. Revue de droit sanitaire et social. 2018 (05): 877.

11. Raude J, Lecrique JM, Lasbeur L, Leon C, Guignard R, Du Roscoät E, Arwidson P. Determinants of preventive behaviors in response to the COVID-19 pandemic in France: comparing the sociocultural, psychosocial, and social cognitive explanations. Frontiers in Psychology. 2020; 11: 584500.

12. Salleras L, Bruguera M, Prat A. Vacuna de la hepatitis B y esclerosis múltiple: una asociación no probada. Medicina clínica. 2006; 126(15): 581-588.

13. Ramdjee B. A vacinação na França: a complexidade do caso francês e a necessária adaptação do regime jurídico às crises sanitárias. Rev. Direito Sanit.(Online). 2023:0026.

14. Bajos N, Spire A, Silberzan L, EPICOV Study Group. The social specificities of hostility toward vaccination against Covid-19 in France. PLoS One. 2022; 17(1): e0262192.

15. Goje O, Kapoor A. Meeting the challenge of vaccine hesitancy. Cleveland Clinic journal of medicine. 2024; 91(9 suppl 1): S50-56.

16. Tapinos D. Pour une approche pragmatique du principe de précaution au service des victimes de dommages corporels: le cas des victimes du vaccin contre l’hépatite B. Médecine & Droit. 2015; 2015(134): 105-14.

17. Comité Consultatif National d’Éthique (CCNE). (2020), Avis n 135: Enjeux éthiques relatifs à la vaccination contre la Covid-19. Paris.

18. Verger P, Fressard L, Collange F, Gautier A, Jestin C, Launay O, Raude J, Pulcini C, Peretti-Watel P. Vaccine hesitancy among general practitioners and its determinants during controversies: a national cross-sectional survey in France. EBioMedicine. 2015; 2(8): 891-897.

19. Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. The Lancet Public Health. 2021; 6(4): e210-221.